No COVID-19 Detour for Global Hematology Therapies
Rachel Narozniak, MA
Published: Wednesday, Apr 29, 2020
With travel restrictions and reduced transportation options, the global spread of coronavirus disease 2019 (COVID-19) has disrupted international networks that supply patients with biological materials needed for sophisticated hematologic therapies.
... to read the full story